Marinus Pharmaceuticals, Inc.
(NASDAQ : MRNS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. 1.56%82.052.1%$228.74m
SAVACassava Sciences, Inc. 18.13%11.470.0%$208.15m
JAZZJazz Pharmaceuticals Plc 1.11%139.582.4%$169.45m
HZNPHorizon Therapeutics Plc 3.88%78.255.8%$167.25m
MRNSMarinus Pharmaceuticals, Inc. 4.21%11.157.8%$124.96m
CORTCorcept Therapeutics, Inc. 1.88%17.095.5%$120.14m
VRXValeant Pharmaceuticals International, Inc. 0.53%15.3014.1%$90.03m
BHCBausch Health Cos., Inc. 0.53%15.300.0%$61.37m
MYOKMyoKardia, Inc. 2.08%132.721.8%$59.58m
AMRNAmarin Corp. Plc 4.67%3.811.5%$56.78m
ARGXargenx SE 2.26%248.570.0%$56.59m
SAGESAGE Therapeutics, Inc. 3.26%60.828.6%$46.31m
GWPHGW Pharmaceuticals Plc 1.97%100.446.2%$39.53m
AXSMAxsome Therapeutics, Inc. 1.44%77.021.9%$39.11m
ICLRICON plc 2.30%183.144.3%$36.29m

Company Profile

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.